Polymyxin B Hemoperfusion and Mortality in Abdominal Septic Shock

Jean Louis Vincent

doi:10.1001/jama.2009.1606

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Letter2014

Short-Acting β-Blocker Administration in Patients With Septic Shock

Diego Orbegozo Cortés, Fabio Silvio Taccone, Jean Louis Vincent

Article2017

Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis

Tomoko Fujii, Riki Ganeko, Yuki Kataoka, Toshi A. Furukawa, Robin Featherstone, Kent Doi, Jean Louis Vincent, Daniela Pasero, René Robert, Claudio Ronco, Sean M. Bagshaw

Article2018

Correction to: Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis

Tomoko Fujii, Riki Ganeko, Yuki Kataoka, Toshi A. Furukawa, Robin Featherstone, Kent Doi, Jean Louis Vincent, Daniela Pasero, René Robert, Claudio Ronco, Sean M. Bagshaw

Article2013

Mortality after surgery in Europe

Rupert M. Pearse, Rui P. Moreno, Peter Bauer, Paolo Pelosi, Philipp Metnitz, Claudia Spies, B. Vallet, Jean Louis Vincent, Andreas Hoeft, Andrew Rhodes

Article2010

Clinical Trial Report—Polymyxin B Hemoperfusion: Effective, or Not?

Jean Louis Vincent